Future research should prioritize elucidating the molecular mechanisms behind the antitumor effects, refining individualized treatment strategies, investigating early tumor prevention applications, assessing potential benefits for non-diabetic populations, advancing the development of novel therapies, establishing robust safety monitoring frameworks, and building precision medicine decision-making platforms
At the follow-up time points, including one month to 1.5 months to three months to six months to 12 months, there were statistically significant differences in pain reduction scores in favor of PRP
International Journal of Molecular Sciences, 25(17), 9351
The unknowns far outweigh the unproven benefits
Diabetes medicines comparison
The rationale is that retatrutide can cause nausea and GI discomfort